DIRAS3 and gastric cancer: The IHC showed down-regulation of p-AKT and up-regulation of α-catenin in DIRAS3-BGC-823 xenograft, possibly indicating that DIRAS3 expression inhibited the malignant behavior of gastric cancer cells by the p-AKT and α-catenin pathways.